ALPS Advisors’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $176K | Buy |
+47,156
| New | +$176K | ﹤0.01% | 1012 |
|
|
2023
Q4 | – | Sell |
-45,028
| Closed | -$226K | – | 1012 |
|
|
2023
Q3 | $226K | Buy |
45,028
+3,363
| +8% | +$16.9K | ﹤0.01% | 948 |
|
|
2023
Q2 | $365K | Buy |
41,665
+10,062
| +32% | +$88K | ﹤0.01% | 695 |
|
|
2023
Q1 | $374K | Buy |
31,603
+6,078
| +24% | +$72K | ﹤0.01% | 653 |
|
|
2022
Q4 | $260K | Buy |
+25,525
| New | +$260K | ﹤0.01% | 945 |
|